Bulgarian Randomized, Double-Blind, Placebo-Controlled Ivermectin Study Shows Positive Results Against COVID-19:

luisenriquereyes | 23 points | Feb 08 2021 14:52:38

Bulgarian Randomized, Double-Blind, Placebo-Controlled Ivermectin Study Shows Positive Results Against COVID-19:

https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002091-12/BG

[-] luisenriquereyes | 4 points | Feb 08 2021 14:53:00

A European Union-based double-blind study, placebo-controlled Phase 2 clinical trial involving ivermectin in 100 patients with mild COVID-19 recently produced results for the world. Based in the Eastern European nation of Bulgaria, the clinical trial was organized after scientists here learned of the data revealing that the drug blocks penetration of SARS-CoV-2’s transport protein into the cell nucleus and thus inhibits or hinders replication, which could possibly be of use in combating this pandemic.

[-] traveler19395 | 4 points | Feb 08 2021 15:41:50

It was completed 4 months ago, what's taking so long? At least the results can't be dismissed as rushed.

[-] akaariai | 2 points | Feb 08 2021 15:44:43

The article mentioned in another comment says they are doing some patent applications...

[-] luisvel | 3 points | Feb 08 2021 15:15:49

Where are you seeing the results?

[-] luisenriquereyes | 3 points | Feb 08 2021 15:33:28

Looks like the results will be published soon. The following link is from a Bulgarian news article translated to English:

https://translate.google.com/translate?sl=bg&tl=en&u=https://www.economic.bg/bg/a/view/finalni-testove-za-izpolzvane-na-ivermektin-v-bylgarija

[-] akaariai | 5 points | Feb 08 2021 15:42:12

The article mentions patenting - any idea what exactly they are looking to patent?

[-] newhavenstumpjumper | 1 points | Feb 08 2021 23:42:18

probably a specific time release version of ivermectin. that's what the big drug cos do when a drug goes off patent. reformulate and patent a different version to keep the big $$$ rolling in.